Intermedin 1-53 Inhibits Myocardial Fibrosis in Rats by Down-Regulating Transforming Growth Factor-β-Reference-Cited by-同舟云学术

Intermedin 1-53 Inhibits Myocardial Fibrosis in Rats by Down-Regulating Transforming Growth Factor-β

Published:2017-01-09 Issue: Volume:23 Page:121-128
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Fang Jian¹,Luan Jiangwei¹,Zhu Gaohong¹,Qi Chang¹,Yang Zhiyong¹,Zhao Sheng¹,Li Bin¹,Zhang Xinzhong¹,Guo Naipeng¹,Li Xiaodong²,Wang Dandan³

Affiliation:

1. Department of Nephrology, Wuhan Medical & Healthcare Center for Women and Children, Wuhan Children’s Hospital, Wuhan Women and Children Care Hospital, Wuhan, Hubei, China (mainland)

2. Department of Nephrology, Wuhan Medical & Healthcare Center for Women and Children, Wuhan Children’s Hospital, Wuhan Women and Children Care Hospital,, Wuhan, Hubei, China (mainland)

3. Department of Internal Medicine-Cardiovascular, Wuhan Medical & Healthcare Center for Women and Children, Wuhan Children’s Hospital, Wuhan Women and Children Care Hospital, Wuhan, Hubei, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure;Journal of Clinical Medicine;2023-02-15

2. Intermedin1–53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis;Inflammation;2022-02-17

3. Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling;Oncotarget;2017-04-19